In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
- 1 January 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 484 (2-3) , 249-257
- https://doi.org/10.1016/j.ejphar.2003.11.027
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Design, Synthesis, and Biological Evaluation of New Inhibitors of the Endocannabinoid Uptake: Comparison with Effects on Fatty Acid AmidohydrolaseJournal of Medicinal Chemistry, 2003
- Endocannabinoids in pain modulationProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Nefopam reduces thermal hypersensitivity in acute and postoperative pain models in the ratPharmacological Research, 2001
- The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular MetabolismJournal of Biological Chemistry, 2001
- The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide HydrolaseJournal of Biological Chemistry, 2001
- Endocannabinoids control spasticity in a multiple sclerosis modelThe FASEB Journal, 2000
- Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric OxideJournal of Biological Chemistry, 2000
- Pharmacology of cannabinoid CB1 and CB2 receptorsPharmacology & Therapeutics, 1997
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992